NAPSA and neoplasm: The tumor cells were immunoreactive for cytokeratin 7 (CK7; Figure 2D), thyroid transcription factor-1 (TTF-1; Figure 2E), and napsin A (Figure 2F) and were negative for CD20, CDX2, P63, chromogranin, synaptophysin, and CD56.